Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Grant of Share Options

25 Sep 2019 07:30

RNS Number : 5368N
Falanx Group Limited
25 September 2019
 

25 September 2019

 

FALANX GROUP LIMITED

(the "Company")

 

Grant of share options

 

Falanx Group Limited (AIM: FLX), the global cyber security and intelligence services provider, announces that Mike Read, CEO, announces that it has today it awarded a total of 28,500,000 options (the "Options") over ordinary shares of nil par value each in the Company ("Ordinary Shares"). A total of 13,000,000 Options have been granted under the Company's existing Enterprise Management Incentive Scheme ("EMI Scheme") and 15,500,000 non-qualifying options have been awarded to certain directors and non-qualifying employees of the Company (the "Non-qualifying Options"). A total of 10,000,000 of the Non-Qualifying Options have been awarded to the following directors:

 

Director

Number of Options granted

Total number of options over Ordinary Shares

Total number of options as a percentage of the Company's issued share capital

 

Mike Read (CEO)

5,000,000

11,500,000

2.87%

Ian Selby (CFO)

5,000,000

11,500,000

2.87%

 

The Options have an exercise price of 1.925 pence per Ordinary Share (the "Exercise Price"), being the closing mid-market price on 24 September 2019, and will vest:

 

·; as to 9,405,000 Options (representing 33% of the total Options) immediately;

·; as to 9,405,000 Options (representing 33% of the total Options), provided that the share price of the Company exceeds 2.89 pence (50% share price growth over the Exercise Price) for a period of one calendar month; and

·; as to the balance of 9,690,000 Options (representing 34% of the total Options), provided that the share price of the Company exceeds 3.85 pence (100% growth over the Exercise Price) for a period of one calendar month.

 

Once vested the Options are exercisable between 1 April 2020 and 31 March 2030, subject to accelerated vesting and exercise in certain customary scenarios.

 

Enquiries:

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

 

Via IFC

Stifel Nicolaus Europe Limited, Nomad and Joint Broker

Fred Walsh / Alex Price / Neil Shah

 

+ 44 (0) 207 710 7600

Turner Pope International Limited, Joint Broker

James Pope / Ben Turner

 

+44 (0) 203 621 4120

 

IFC Advisory Ltd

Financial PR & IR

Graham Herring / Miles Nolan / Zach Cohen

+44 (0) 203 934 663

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. For more information: http://www.falanx.com/

Notification and public disclosure of transactions by persons discharging managerial responsibilities ("PDMRs") and persons closely associated ("PCA") with them.

  1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

Michael David Read

2

 

Reason for the notification

a)

 

Position/status

 

CEO

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Falanx Group Limited

b)

 

LEI

 213800YO4F9CUQLALV19

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of nil par value

b)

Identification code 

 

VGG3338A1075

c)

 

Nature of the transaction 

 

Grant of options over Ordinary Shares

d)

 

Price(s) and volume(s)

Volume(s):

5,000,000 Ordinary Shares

Price: 1.925 pence per Ordinary Share

d)

 

Aggregated information 

- Aggregated volume

- Price

N/A

 

e)

 

Date of the transactions 

25 September 2019

f)

 

Place of the transaction

Outside a trading venue

 

  1

 

Details of the person discharging managerial responsibilities / person closely associated 

a)

 

Names 

Ian Selby

2

 

Reason for the notification

a)

 

Position/status

 

CFO

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

Falanx Group Limited

b)

 

LEI

 213800YO4F9CUQLALV19

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Ordinary Shares of nil par value

b)

Identification code 

 

VGG3338A1075

c)

 

Nature of the transaction 

 

Grant of options over Ordinary Shares

d)

 

Price(s) and volume(s)

Volume(s):

5,000,000 Ordinary Shares

Price: 1.925 pence per Ordinary Share

d)

 

Aggregated information 

- Aggregated volume

- Price

N/A

 

e)

 

Date of the transactions 

24 September 2019

f)

 

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKQDQOBKDOCB
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.